Northrop Grumman (NYSE:NOC) CEO Sells $14,176,400.00 in Stock

Northrop Grumman Corporation (NYSE:NOC) CEO Kathy Warden sold 20,000 shares of the business’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $708.82, for a total transaction of $14,176,400.00. Following the completion of the sale, the chief executive officer directly owned 171,602 shares of the company’s stock, valued at approximately $121,634,929.64. This trade represents a 10.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Northrop Grumman Trading Down 1.9%

Shares of NYSE:NOC traded down $13.02 during trading on Tuesday, reaching $685.00. 956,138 shares of the company were exchanged, compared to its average volume of 972,008. The business’s fifty day simple moving average is $615.57 and its 200-day simple moving average is $595.92. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.10 and a quick ratio of 1.01. Northrop Grumman Corporation has a 12-month low of $426.24 and a 12-month high of $715.61. The firm has a market capitalization of $97.22 billion, a PE ratio of 23.52, a P/E/G ratio of 5.18 and a beta of 0.04.

Northrop Grumman (NYSE:NOC) last announced its quarterly earnings data on Tuesday, January 27th. The aerospace company reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.97 by $0.26. The company had revenue of $11.71 billion for the quarter, compared to analysts’ expectations of $11.61 billion. Northrop Grumman had a return on equity of 25.57% and a net margin of 9.97%.Northrop Grumman’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.39 earnings per share. Northrop Grumman has set its FY 2026 guidance at 27.400-27.900 EPS. On average, research analysts anticipate that Northrop Grumman Corporation will post 28.05 EPS for the current year.

Northrop Grumman Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 17th. Stockholders of record on Monday, December 1st were issued a $2.31 dividend. The ex-dividend date was Monday, December 1st. This represents a $9.24 annualized dividend and a dividend yield of 1.3%. Northrop Grumman’s payout ratio is currently 31.72%.

Analysts Set New Price Targets

A number of brokerages recently commented on NOC. JPMorgan Chase & Co. boosted their price objective on shares of Northrop Grumman from $575.00 to $640.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 22nd. UBS Group boosted their price target on Northrop Grumman from $777.00 to $778.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Jefferies Financial Group upped their price objective on Northrop Grumman from $630.00 to $690.00 and gave the stock a “hold” rating in a research note on Sunday, February 1st. Argus set a $785.00 target price on Northrop Grumman in a research note on Tuesday. Finally, BNP Paribas Exane began coverage on shares of Northrop Grumman in a report on Tuesday, November 18th. They issued an “outperform” rating and a $710.00 target price for the company. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $693.60.

Institutional Investors Weigh In On Northrop Grumman

Large investors have recently modified their holdings of the business. Parvin Asset Management LLC acquired a new stake in Northrop Grumman in the 2nd quarter worth approximately $25,000. Torren Management LLC acquired a new stake in shares of Northrop Grumman during the fourth quarter worth $26,000. Financial Life Planners acquired a new stake in shares of Northrop Grumman during the third quarter worth $27,000. Physician Wealth Advisors Inc. grew its holdings in shares of Northrop Grumman by 200.0% during the third quarter. Physician Wealth Advisors Inc. now owns 48 shares of the aerospace company’s stock valued at $29,000 after buying an additional 32 shares during the last quarter. Finally, Kohmann Bosshard Financial Services LLC acquired a new position in shares of Northrop Grumman in the 4th quarter valued at $29,000. Hedge funds and other institutional investors own 83.40% of the company’s stock.

Northrop Grumman Company Profile

Northrop Grumman Corporation (NYSE: NOC) is a leading U.S.-based aerospace and defense company that designs, builds and sustains advanced systems, products and technologies for government and commercial customers. Formed through the combination of Northrop and Grumman businesses in the 1990s, the company’s portfolio spans manned and unmanned aircraft, space systems, missile defense, radar and sensor systems, and integrated command, control, communications, computers, intelligence, surveillance and reconnaissance (C4ISR) solutions.

The company’s work includes airframe and platform manufacturing, space hardware and satellite systems, advanced mission systems and cybersecurity services, as well as logistics, sustainment and modernization programs.